Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Richard J. Battafarano et al.|New England Journal of Medicine|2018Cited by 2.1k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Kellie N. Smith et al.|Cancer Discovery|2016Cited by 897
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Patrick M. Forde et al.|Cancer Research|2018Cited by 313
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerValsamo Anagnostou, Victor E. Velculescu, Noushin Niknafs et al.|Nature Cancer|2020Cited by 207
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful ActivityValsamo Anagnostou, Patrick M. Forde, Mark Yarchoan et al.|Clinical Cancer Research|2017Cited by 181